Table 2 Number of observed second primary cancers (Obs) following breast cancer, diagnosed between 1958 and 2000, standardised incidence ratios (SIRs), and 95% confidence interval (CI) for second primary malignancy according to age at breast cancer diagnosis

From: Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study

 

Age at breast cancer diagnosis

 

<50 years

50 years

 

Second primary cancer site

Obs

SIR

95% CI

Obs

SIR

95% CI

Ratio

Oesophagus

20

2.54

(1.55–3.78)

96

1.38

(1.12–1.67)

1.84*

Stomach

97

2.18

(1.77–2.63)

589

1.32

(1.22–1.43)

1.65*

Colorectum

278

1.38

(1.23–1.58)

1645

1.12

(1.06–1.17)

1.24*

Pancreas

74

1.60

(1.26–1.99)

397

1.06

(0.96–1.16)

1.51*

Lung

235

2.35

(2.06–2.66)

482

1.14

(1.04–1.24)

2.07*

Endometrium

183

1.29

(1.11–1.49)

823

1.61

(1.50–1.72)

0.80*

Ovary

247

1.97

(1.73–2.22)

465

1.08

(0.98–1.18)

1.82*

Kidney

74

1.50

(1.18–1.86)

369

1.28

(1.15–1.41)

1.17

Melanoma

91

1.32

(1.06–1.61)

269

1.25

(1.10–1.40)

1.06

Nervous system

89

1.25

(1.00–1.52)

278

1.14

(1.01–1.27)

1.10

Thyroid

51

2.21

(1.65–2.86)

113

1.36

(1.12–1.63)

1.62*

Endocrine glands

75

1.36

(1.07–1.68)

195

1.01

(0.87–1.15)

1.35*

Connective tissue

40

3.27

(2.33–4.36)

89

1.48

(1.19–1.80)

2.21*

Thorax and upper limbs

19

8.02

(4.82–12.03)

42

3.46

(2.49–4.58)

2.32*

Non-Hodgkin's lymphoma

77

1.51

(1.19–1.87)

313

1.06

(0.95–1.19)

1.42*

Leukaemia

61

1.81

(1.38–2.29)

282

1.30

(1.15–1.46)

1.39*

 Acute lymphatic leukaemia

2

1.20

(0.14–3.45)

20

2.19

(1.34–3.26)

0.55

 Chronic lymphatic leukaemia

14

1.15

(0.63–1.84)

87

0.96

(0.77–1.17)

1.21

 Acute myeloid leukaemia

22

1.97

(1.23–2.88)

91

1.46

(1.17–1.77)

1.35

 Chronic myeloid leukaemia

13

2.89

(1.53–4.67)

33

1.56

(1.08–2.14)

1.85

All the above sites

1692

1.64

(1.56–1.72)

6405

1.20

(1.17–1.23)

1.36*

  1. Standardised incidence ratio for women <50 years of age at breast cancer diagnosis was compared with SIR for women 50 years of age at breast cancer diagnosis (ratio).
  2. Bold denotes statistical significance; * denotes statistically significant ratio.